BILL ANALYSIS

S3362

NEUTRAL

Health Marketplace and Savings Accounts for All Act

S3362 (Health Marketplace and Savings Accounts for All Act) has been assessed with a neutral outlook for investors. This legislation directly affects HCA Healthcare ($HCA). The primary sectors impacted are Healthcare and Finance. View the full bill text on Congress.gov.

neutral

Market Sentiment

Affected Stocks

Sectors Impacted

Key Takeaways for Investors

S.3362 is early-stage, not a current market mover — negligible immediate trading impact.

Long-term structural shift to HDHPs benefits UNH's Optum segment and HSA administrators, but effect is <0.2% of UNH revenue.

No appropriation or direct spending — tax expenditure only; no catalyst until committee markup or companion bill in House.

How S3362 Affects the Market

No real market price data is provided for current tickers, but structurally, this bill does not move any stock meaningfully at the early legislative stage. Healthcare sector investors should note the direction of travel — expanding HSA eligibility and contribution limits is a bipartisan trend that incrementally supports managed care companies (, $CVS, $ELV) and HSA custodians. However, with zero committee momentum, no capital deployment, and a single sponsor, this is a watchlist item, not a trade.

Bill Details

Metric	Value
Bill Number	S3362
Market Sentiment	neutral
Event Date	December 4, 2025
Affected Sectors	Healthcare, Finance
Affected Stocks	HCA Healthcare ($HCA)
Source	View on Congress.gov →

Summary

Sen. Rand Paul's S.3362 proposes expanding HSA contribution limits to parity with 401(k) deferrals and broadening qualified expenses to include gym memberships and supplements. The bill is in early legislative stage (referred to Finance Committee) with no companion in the House and no appropriations attached. Near-term market impact is negligible; long-term structural shift toward HDHP enrollment benefits insurance administrators and HSA custodians modestly.

Full AI Market Analysis

S.3362 was introduced on December 4, 2025 by Sen. Rand Paul (R-KY) and referred to the Senate Finance Committee, where it remains. The bill proposes to raise HSA contribution limits to match 401(k) elective deferral limits (currently $23,000 for under-50, plus $7,500 catch-up for 50+), and allows HSA funds to pay for health insurance premiums, direct primary care arrangements, gym memberships, vitamins, and wearable trackers. It also permits rollovers to children or parents and extends bankruptcy protections. The money trail: This is a tax expenditure bill — it does not appropriate any federal spending. Instead, it reduces federal revenue by allowing more pre-tax or tax-deductible contributions to HSAs. The Joint Committee on Taxation would score this as a revenue loss; no direct spending authority is created. Actual adoption requires passage by both chambers and signature. The bill's early stage (referred to committee, no hearings scheduled) means zero near-term market catalyst. Structural winners: UnitedHealth Group stands to benefit modestly because its Optum financial services unit administers HSAs and its insurance arm (UnitedHealthcare) sells HDHPs. Revenue impact is likely $150-500M annually if passed, which is less than 0.2% of UNH's $371.6B revenue. HCA ($HCA) sees minor working capital improvements from faster patient payments. Kenvue ($KVUE) — not JNJ — is the correct consumer health pure-play beneficiary from broader OTC/HSA eligibility, but JNJ's remaining stake is too small to matter. Structural losers: No clear losers identified. Traditional insurance plans (PPOs) may see erosion of enrollment share to HDHPs, but the largest carriers (UNH, Anthem, Aetna/CVS) all offer both product types and would offset losses with new HDHP/HSA revenue. Timeline: The 119th Congress runs through January 2027. S.3362 is a single-sponsor bill from a junior ranking member (not committee leadership). No companion bill exists in the House. Given the current political environment, this bill has very low probability of passage in its current form. Similar HSA expansion bills have been introduced in multiple prior Congresses without advancement.